Yaichiro Kotake Selected Research

1-methyl-1,2,3,4-tetrahydroisoquinoline

7/2006	Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.
5/2002	Determination method of 1-methyl-1,2,3, 4-tetrahydroisoquinoline, an endogenous parkinsonism-preventing substance, by radioimmunoassay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaichiro Kotake Research Topics

Disease

7	Parkinsonian Disorders (Parkinsonism) 09/2014 - 05/2002
5	Parkinson Disease (Parkinson's Disease) 01/2018 - 11/2002
5	Neuroblastoma 01/2014 - 06/2004
4	Carcinoma (Carcinomatosis) 04/2016 - 05/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Inflammation (Inflammations) 09/2021
1	Alzheimer Disease (Alzheimer's Disease) 09/2021
1	Cognitive Dysfunction 09/2021
1	Liver Diseases (Liver Disease) 01/2019
1	Cholestasis 01/2019
1	Starvation 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2012
1	Tauopathies 10/2006
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 06/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2002

Drug/Important Bio-Agent (IBA)

4	1,2,3,4-tetrahydroisoquinolineIBA 01/2018 - 11/2002
4	tributyltinIBA 04/2016 - 05/2013
4	NeurotoxinsIBA 01/2014 - 11/2002
3	NAD (NADH)IBA 04/2016 - 08/2014
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2016 - 08/2014
3	1,2,3,4- tetrahydro- 1- (phenylmethyl)isoquinolineIBA 01/2014 - 11/2002
2	Messenger RNA (mRNA)IBA 09/2022 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 05/2013
2	isocitric acid (isocitrate)IBA 04/2016 - 08/2015
2	Dopamine (Intropin)FDA LinkGeneric 09/2014 - 07/2006
2	1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinolineIBA 09/2014 - 11/2002
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2014 - 01/2014
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2007 - 06/2004
2	1-methyl-1,2,3,4-tetrahydroisoquinolineIBA 07/2006 - 05/2002
1	TrehaloseIBA 09/2022
1	DisaccharidesIBA 09/2022
1	Felbamate (Felbatol)FDA Link 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Vorinostat FDA Link 09/2021
1	Histone Deacetylase InhibitorsIBA 09/2021
1	Therapeutic UsesIBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	Clodronic Acid (Clodronate)IBA 09/2021
1	CytokinesIBA 09/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2021
1	Minocycline (Cyclops)FDA LinkGeneric 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 08/2015
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 09/2014
1	catechol (pyrocatechol)IBA 09/2014
1	AMP-Activated Protein KinasesIBA 05/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2012
1	TubulinIBA 09/2010
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2007
1	salsolinolIBA 07/2006
1	reticulineIBA 06/2004
1	N-methylcoculaurineIBA 06/2004
1	BenzylisoquinolinesIBA 06/2004
1	Herbal TeasIBA 06/2004
1	Serum AlbuminIBA 05/2002